Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News. cmAngio “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” with AI that maximizes the mammogram for both breast cancer and heart disease detection.
